FDAnews
www.fdanews.com/articles/180676-diacarta-nabs-ce-ivd-for-its-non-invasive-colorectal-cancer-test

DiaCarta Nabs CE-IVD for its Non-Invasive Colorectal Cancer Test

February 27, 2017

California–based DiaCarta has achieved CE-IVD approval for ColoScapeTM, a colorectal cancer mutation detection kit.

The device is designed to detect mutations in DNA extracted from solid tumor, plasma or stool samples. It can complete an assay in less than 2.5 hours.

View today's stories